KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

REQUIP 0.25 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

0.25 MG

 

GENERIC NAME:

ROPINIROLE

 

MANUFACTURER:

SMITH KLINE BEECHAM

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Parkinson's disease

 

SIDE EFFECTS:

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

 

ADULT DOSE:

Parkinson"s disease, idiopathic- Oral, initially 0.25 mg three times a day . Based on patient response, dosage should be increased at weekly intervals . A suggested schedule for titration follows: Ascending Dosage Schedule of Ropinirole Week Dosage Total Daily Dose 1 0.25 mg three times a day 0.75 mg 2 0.5 mg three times a day 1.5 mg 3 0.75 mg three times a day 2.25 mg 4 1 mg three times a day 3 mg

 

MAXIMUM ADULT DOSE:

24 mg a day .

 

PEDIATRIC DOSE:

Safety and efficacy have not been established .  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT